Peer Review History
| Original SubmissionSeptember 29, 2025 |
|---|
|
-->PONE-D-25-52841-->-->Constructing HIV/AIDS in Chinese Media (2011-2024): A Mixed-Methods Study-->-->PLOS One Dear Dr. Shi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Feb 06 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:-->
-->If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Xiaoming Tian, Ph.D. Academic Editor PLOS One Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please note that PLOS One has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, we expect all author-generated code to be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse. 3. Please upload a new copy of Figure 1 as the detail is not clear. Please follow the link for more information: https://journals.plos.org/plosone/s/figures 4. Thank you for providing your underlying data as Supporting Information. We note that the data set contains text or data that is not in English. Please note that PLOS is an English-language publisher, so we require data sets to be provided in English as well. Please upload an English-language version of your data set. This will also allow us to determine if your data follows PLOS standards per our Data Availability policy here: https://journals.plos.org/plosone/s/data-availability 5. We note that there is identifying data in the Supporting Information file <AIDS Corpus.xlsx>. Due to the inclusion of these potentially identifying data, we have removed this file from your file inventory. Prior to sharing human research participant data, authors should consult with an ethics committee to ensure data are shared in accordance with participant consent and all applicable local laws. Data sharing should never compromise participant privacy. It is therefore not appropriate to publicly share personally identifiable data on human research participants. The following are examples of data that should not be shared: -Name, initials, physical address -Ages more specific than whole numbers -Internet protocol (IP) address -Specific dates (birth dates, death dates, examination dates, etc.) -Contact information such as phone number or email address -Location data -ID numbers that seem specific (long numbers, include initials, titled “Hospital ID”) rather than random (small numbers in numerical order) Data that are not directly identifying may also be inappropriate to share, as in combination they can become identifying. For example, data collected from a small group of participants, vulnerable populations, or private groups should not be shared if they involve indirect identifiers (such as sex, ethnicity, location, etc.) that may risk the identification of study participants. Additional guidance on preparing raw data for publication can be found in our Data Policy (https://journals.plos.org/plosone/s/data-availability#loc-human-research-participant-data-and-other-sensitive-data) and in the following article: http://www.bmj.com/content/340/bmj.c181.long. Please remove or anonymize all personal information (Names), ensure that the data shared are in accordance with participant consent, and re-upload a fully anonymized data set. Please note that spreadsheet columns with personal information must be removed and not hidden as all hidden columns will appear in the published file. Reviewers' comments: Reviewer's Responses to Questions -->Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. --> Reviewer #1: Yes Reviewer #2: Partly ********** -->2. Has the statistical analysis been performed appropriately and rigorously? --> Reviewer #1: Yes Reviewer #2: Yes ********** -->3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #1: Yes Reviewer #2: Yes ********** -->4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.--> Reviewer #1: Yes Reviewer #2: Yes ********** -->5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)--> Reviewer #1: This study examines 39,141 news articles published between 2010 and 2024 to understand the evolving media discourse surrounding HIV/AIDS. Employing Analysis of Topic Model Networks (ANTMN) and collocation analysis, we extract the thematic networks, terminology for people living with HIV (PLHIV), and HIV/AIDS metaphors. Multiple Correspondence Analysis (MCA) and network backbone method were complementarily employed to examine the interrelationships among discursive strategies and their connections with thematic contexts. In my opinion, this is an excellent paper characterized by rigorous logic, sound methodology, proficient English expression, reliable data, and credible conclusions. However, there are several minor issues that. Imprecise language expression: The phrase "particularly in contexts like China" is mentioned in lines 49–50. Please briefly elaborate on why China is specifically highlighted in this context. Formatting inconsistencies: In line 74, two references are enclosed in square brackets with a comma between them, which does not comply with the formatting requirements; similar issues exist elsewhere in the text. An extra comma is present in line 133. The meaning of decimals and percentages next to the axes in Figures 3 and 4 is unclear—annotations should be provided to clarify these. Unclear research significance: It is recommended that the authors carefully elaborate, before the methodology section, on the significance of studying traditional media in the current era of highly prevalent social media. Specifically, please clarify: "What is the importance of researching traditional media when social media is so dominant?" Superficial discussion on addressing deficiencies: While the paper identifies certain deficiencies in traditional media’s coverage of HIV-related topics, the discussion section only offers general remarks on how to improve these shortcomings. The authors are advised to provide targeted countermeasures and suggestions tailored to these specific deficiencies. Reviewer #2: Firstly, this manuscript is technically sound and the data could support most part of the conclusion,and the statistical analysis has been performed relatively appropriately. However, for some part of data presented in the Result section, I couldn't find the further analysis and explanation in Discussion section. For example, when discussing the themes identified in this research, the fourth one "Medicine“ is not mentioned in "Key finding" part. For another example, the second category of the result presented is "Changes over time", but I didn't find any further analysis and explanation on this in discussion section. I don't know whether it is one of the major findings of this research. Secondly, as far as I could see, all data collected in this research (including figures and tables) has been included at the end of the manuscript. Thirdly, as an academic paper, this manuscript is presented with the logical structure and in an intelligible fashion. The language is generally clear, correct and unambiguous, but as for the subtitle "Key Findings", "Major Findings" may be more accepted substitute. ********** -->6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.--> Reviewer #1: Yes: He Hu Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. --> |
| Revision 1 |
|
-->PONE-D-25-52841R1-->-->Constructing HIV/AIDS in Chinese Media (2011-2024): A Mixed-Methods Study-->-->PLOS One Dear Dr. Shi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Apr 16 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:-->
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Xiaoming Tian, Ph.D. Academic Editor PLOS One Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments: I now have time to read the revised manuscript carefully and the comments from the three reviewers. After a thorough review of the revised manuscript and the feedback from all three reviewers, I have determined that this manuscript requires major revision before it can be considered for publication. The core concerns raised by the reviewers, particularly the reviewer who recommended rejection, highlight critical areas that need to be addressed to meet the journal’s publication standards. First, you need to clearly articulate the novel contribution of the study. While your large-scale (39,141 articles) and long-term (15-year) analysis has the potential to offer new insights, the current manuscript fails to explicitly contrast your findings with prior research. Please highlight the unique discoveries of your study, such as the identification of understudied stigmatizing terminologies (e.g., spatialized terms like “AIDS Town” and “AIDS Apartment”) and the novel analysis of the associations between thematic contexts, PLHIV (people living with HIV) terminologies, and HIV/AIDS metaphors. Additionally, explain how these findings fill gaps in the existing literature. Next, please provide a convincing explanation for selecting 2011 as the starting point of your analysis. Clarify whether this year corresponds to a major policy shift, epidemiological change, or transformation in the Chinese media system. Address the broader structural decline in the influence of traditional mainstream media in the digital era, and clearly explain the contemporary significance of focusing exclusively on traditional media outlets in your study. The current manuscript only briefly cites earlier studies but does not meaningfully situate your findings in relation to them. Please add a section in the discussion to explicitly discuss whether your results confirm, challenge, or extend existing knowledge, and clearly articulate how this study advances debates in health communication, risk communication, or media discourse analysis. Additionally, please clarify that your study analyzes the full text of news articles (not just headlines) that contain HIV-related keywords, to eliminate any misunderstanding from the reviewer. Complement your automated text mining techniques with more qualitative validation, such as manual coding and interpretive analysis of a subset of articles, to enhance the reliability and depth of your findings. Although your empirical focus is on China, the current discussion does not extract broader theoretical implications for global health communication or media studies. Please add a section to explain how your findings contribute to international scholarship, and discuss the potential transferability of your results to other contexts. Finally, demonstrate how your computational analysis produces substantively new insights or reveals patterns that could not have been identified through existing approaches, and move beyond descriptive analysis to achieve a higher level of theoretical advancement. Please revise your manuscript thoroughly in response to these comments and resubmit it for further review. When you resubmit, please provide a detailed point-by-point response to each of the three reviewers’ comments, explaining how you have addressed them in the revised manuscript. I look forward to receiving your revised manuscript. Xiaoming Tian [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions -->Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.--> Reviewer #3: (No Response) Reviewer #4: All comments have been addressed Reviewer #5: (No Response) ********** -->2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. --> Reviewer #3: Yes Reviewer #4: Partly Reviewer #5: (No Response) ********** -->3. Has the statistical analysis been performed appropriately and rigorously? --> Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: (No Response) ********** -->4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: (No Response) ********** -->5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.--> Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: (No Response) ********** -->6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)--> Reviewer #3: 1. Please check the formatting throughout. Some of the paragraphs too long and really hard for the reader to read. 2. Suggest to put why 14 years of study because the duration of the publications used too old and dynamic of the situations not really addressed here. Maybe 10 years is still ok. 3. The transformation of issues in current media (social media or current policies) should also addressed here. Reviewer #4: 1. The Discussion section fails to fully address the research gaps outlined in the Introduction, nor does it establish a systematic, multi-dimensional critical dialogue and comparative analysis with the classic domestic and international studies and cutting-edge field-specific research reviewed in the same section. 2. The manuscript does not proactively acknowledge its core limitations, including sampling frame bias, the omission of media heterogeneity analysis, and subjectivity in coding procedures, which compromises the overall academic rigor of the study. 3. The proposed recommendations for future research are overly broad, and do not put forward specific, extensible research directions closely aligned with the research gaps identified in this paper. Reviewer #5: The central limitation of this paper is its lack of a genuinely novel research contribution. Although the authors position the study as “enriching the interpretation of HIV/AIDS and social cognition in the Chinese context”, a substantial body of scholarship—both in Chinese and international communication studies—has already examined media framing, stigma construction, metaphor use, and agenda-setting in HIV reporting. From this perspective, the manuscript’s original contribution remains unclear. The findings largely reiterate established observations, such as the persistence of stigmatizing narratives and the dominance of macro-political frames. I would strongly encourage the authors to reconsider their research question and clarify what new insight this study offers beyond existing literature. At its current stage, the manuscript does not yet meet the standard for publication. The framing of the research design is also problematic. The authors select 2011 as the starting point of analysis but do not provide a convincing justification for why this year constitutes a meaningful turning point in HIV communication or media practice. It is unclear whether this choice reflects a major policy shift, epidemiological change, or transformation in the media system. Moreover, the manuscript does not address the broader structural decline in the influence of traditional mainstream media in the digital era, which raises questions about the contemporary significance of focusing exclusively on such outlets. Without a clear rationale for the temporal scope and media selection, the analytical framework appears arbitrary rather than theoretically grounded. The manuscript also demonstrates insufficient engagement with prior scholarship. Although earlier studies are briefly cited, the paper does not meaningfully situate its findings in relation to them. There is little discussion of whether the results confirm, challenge, or extend existing knowledge, nor is there a clear articulation of how this study advances debates in health communication, risk communication, or media discourse analysis. As a result, the research appears disconnected from the cumulative development of the field. There are significant weaknesses in the methodological design and use of data. The study claims to analyse “media discourse construction,” yet the dataset consists primarily of news headlines containing HIV-related keywords. Headlines alone cannot adequately capture discursive structures, narrative strategies, source diversity, or contextual framing. This creates a mismatch between the stated research objectives and the empirical material. Furthermore, the manuscript characterises the approach as mixed-methods, but the analysis relies almost entirely on automated text mining techniques, with little evidence of qualitative validation, manual coding, or interpretive analysis. The methodological transparency and reliability of the findings are therefore difficult to assess. Several of the paper’s central claims are insufficiently supported by evidence. Assertions regarding the persistence of stigma, the prevalence of war metaphors, and the dominance of political narratives are presented as major findings, yet these patterns have been widely documented in previous research. The manuscript does not demonstrate how the computational analysis produces substantively new insights or reveals patterns that could not have been identified through existing approaches. Consequently, the study remains largely descriptive and does not achieve the level of theoretical advancement expected for publication. Finally, the manuscript does not clearly articulate its relevance for an international readership. While the empirical focus is on China, the discussion does not extract broader theoretical implications for global health communication or media studies. Without a clearer statement of how the findings contribute to international scholarship, the paper’s significance remains limited. In summary, the manuscript addresses a potentially important topic but is constrained by insufficient originality, weak theoretical grounding, and limited engagement with prior research. Substantial reconceptualisation would be required for the study to make a meaningful scholarly contribution. For these reasons, I cannot recommend the manuscript for publication in its current form. ********** -->7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.--> Reviewer #3: No Reviewer #4: No Reviewer #5: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.
|
| Revision 2 |
|
-->PONE-D-25-52841R2-->-->Constructing HIV/AIDS in Chinese Media (2010-2024): A Mixed-Methods Study-->-->PLOS One Dear Dr. Shi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by May 29 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:-->
--> If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only the individual author can complete the verification step; PLOS staff cannot verify ORCID iDs on behalf of authors. We look forward to receiving your revised manuscript. Kind regards, Xiaoming Tian, Ph.D. Academic Editor PLOS One Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments : Dear Authors, Thank you for your revised manuscript and detailed responses to the reviewers. The manuscript has been substantially improved and is now close to acceptance. However, several specific, fixable errors must be corrected before final acceptance. Below are the required revisions with clear references to the manuscript text. 1.Grammatical and subject-verb agreement errors Abstract: “stigmatizing terminology persist” Introduction: “one of the leading cause” Persistent issues with verb number, noun number, and awkward phrasing appear throughout the manuscript. 2.Inconsistent terminology and labeling Inconsistent reference to affected populations: PLHIV, people living with HIV, HIV patients, AIDS patients are used interchangeably. Inconsistent pluralization: metaphor / metaphors, journey metaphor / journey metaphors vary across sections. 3.Conflicting numerical values across sections Sample size: 40,038 raw; 39,141 valid in Methods, but inconsistent rounding appears in the Abstract, cover letter, and responses. Topic number: 50 topics during modeling vs. 48 topics in Results; these values must be aligned. 4.Insufficient methodological transparency Mixed-methods validation: No explicit number of articles used for qualitative coding, no coder details, and no exact Krippendorff’s Alpha value reported. Multiple Correspondence Analysis (MCA): No eigenvalues or dimension contribution rates reported in the results. 5.Incomplete result presentation and unclear tables Table 4 lacks clear annotation, sample size, and coding rules. Usage rates in Tables 1 and 2 show inconsistent decimal places. MCA results lack sufficient statistical supporting information. 6.Formatting and presentation flaws References show inconsistent DOI formatting, journal abbreviations, and citation style. Subheading numbering is disorganized; some paragraphs remain overly long. Unremoved revision traces and inconsistent line spacing are present. This is a minor revision. Once you correct these issues, I will recommend the manuscript for formal acceptance in PLOS ONE. Sincerely, Xiaoming [Note: HTML markup is below. Please do not edit.] [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. --> |
| Revision 3 |
|
<p>Constructing HIV/AIDS in Chinese Media (2010-2024): A Mixed-Methods Study PONE-D-25-52841R3 Dear Dr. Shi, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Xiaoming Tian, Ph.D. Academic Editor PLOS One Additional Editor Comments (optional): Congrats on the revisions - very well done! Xiaoming Reviewers' comments: |
| Formally Accepted |
|
PONE-D-25-52841R3 PLOS One Dear Dr. Shi, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Xiaoming Tian Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .